Related Articles
Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer
A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel
A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens
Personalized peptide vaccination in patients with refractory non-small cell lung cancer